Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells

Angiopoietin-1 negatively regulates expression and activity of tissue factor in endothelial cells
复制标题

DOI:
10.1096/fj.01-0556fje
复制
发表时间:
2001-11-01
期刊:
影响因子:
4.8
通讯作者:
Koh, GY
Koh, GY
中科院分区:
生物学2区
文献类型:
--
作者:
Kim, I;Oh, JL;Koh, GY

文献摘要

被引文献

相似文献

正常情况下,组织因子(TF)不在内皮细胞表面表达,但其表达可由血管内皮生长因子(VEGF)和肿瘤坏死因子(TNF)-α诱导。然而,影响这种诱导的信号通路是未知的。使用人脐静脉内皮细胞,我们发现富含鸟嘌呤-胞嘧啶的DNA结合蛋白和核因子(NF)-κ B抑制剂抑制VEGF和TNF-α诱导的TF表达和活性。然而,出乎意料的是,磷脂酰肌醇(PI)3 '-激酶抑制剂增强了VEGF和TNF-α诱导的TF表达和活性。血管生成素-1(Ang 1)是细胞内PI 3 '-激酶/Akt的强激活剂,可抑制VEGF和TNF-α对TF的诱导,而Ang 1本身对TF无明显影响。通过使用腺病毒转移选择性激活(或失活)PI 3 '-激酶/Akt降低(或增强)TNF-α诱导的TF mRNA和蛋白质表达,而与Ang 1处理无关。根据这些结果,我们得出结论,Ang 1抑制TF表达的上调,可能通过激活内皮细胞中的PI 3 '-激酶/Akt。Ang 1可用作VEGF和TNF-α诱导的凝血、炎症和癌症进展的抑制剂。
Normally, tissue factor (TF) is not expressed on the surface of endothelial cells, but its expression can be induced by vascular endothelial growth factor (VEGF) and tumor necrosis factor (TNF)-alpha. However, the signaling pathway(s) affecting this induction is unknown. Using human umbilical vein endothelial cells, we found that inhibitors of guanine-cytosine-rich DNA binding protein and nuclear factor (NF)-kappaB suppressed VEGF- and TNF-alpha -induced expression and activity of TF. However, unexpectedly, phosphatidylinositol (PI) 3'-kinase inhibitor enhanced the VEGF- and TNF-alpha -induced expression and activity of TF. Angiopoietin-1 (Ang1), a strong activator of intracellular PI 3'-kinase/Akt, inhibited the induction of TF by VEGF and TNF-alpha, whereas Ang1 itself did not produce any significant effect on TF. Selective activation (or inactivation) of PI 3'-kinase/Akt by using adenoviral transfer reduced (or enhanced) TNF-alpha -induced expression of TF mRNA and protein, regardless of Ang1 treatment. From these results, we conclude that Ang1 inhibits the up-regulation of TF expression, possibly through activation of PI 3'-kinase/Akt in endothelial cells. Ang1 may be useful as an inhibitor of VEGF- and TNF-alpha -induced coagulation, inflammation, and cancer progression.